Mycobacterium bovis infection of a femorofemoral bypass graft following intravesical Bacillus Calmette–Guérin (BCG) immunotherapy

Mycobacterium bovis infection of a femorofemoral bypass graft following intravesical Bacillus Calmette–Guérin (BCG) immunotherapy

Vascular bypass graft infection with Mycobacterium bovis following Bacillus Calmette–Guérin (BCG) immunotherapy for bladder cancer is an incredibly rare complication. We present the case of an 85-year-old man with a history of femorofemoral bypass who developed this complication over a year after BC...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical tuberculosis and other mycobacterial diseases 2020-05, Vol.19, p.100152, Article 100152
Hauptverfasser: Meyer, Ryan K., Williams, Stephen J., Lee, Thomas Y.
Format: Artikel
Sprache:eng
Schlagworte:
Bacillus Calmette–Guérin
Bladder cancer
Mycobacterium bovis
Pembrolizumab
Prosthetic bypass graft infection
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Vascular bypass graft infection with Mycobacterium bovis following Bacillus Calmette–Guérin (BCG) immunotherapy for bladder cancer is an incredibly rare complication. We present the case of an 85-year-old man with a history of femorofemoral bypass who developed this complication over a year after BCG treatment. He was successfully treated with explantation of the polytetrafluoroethylene (PTFE) graft, redo bypass with vein graft, and antituberculous medical therapy.
ISSN:2405-5794
2405-5794
DOI:10.1016/j.jctube.2020.100152